OpenEvidence raises $250M at $15B valuation
OpenEvidence has raised $250 million in a funding round led by Andreessen Horowitz and Byers Capital, valuing the AI clinical decision-support platform at $15 billion. Daniel Nadler, PhD, founder and CEO of OpenEvidence, confirmed the raise and its lead investors in a Sept. 28 email to Becker’s. Forbes first reported the raise earlier in September, […] The post OpenEvidence raises $250M at $15B valuation appeared first on Becker's Hospital Review | Healthcare News & Analysis...
Original Source
Read the full article at Beckershospitalreview →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.